Q2 EPS Estimate for Ovid Therapeutics Reduced by Analyst
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Analysts at HC Wainwright decreased their Q2 2025 EPS estimates for shares of Ovid Therapeutics in a research note issued to investors on Tuesday, May 27th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of ($0.14) for the quarter, down […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Analysts at HC Wainwright decreased their Q2 2025 EPS estimates for shares of Ovid Therapeutics in a research note issued to investors on Tuesday, May 27th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of ($0.14) for the quarter, down […]
